Praesidio signs distribution agreement with Pure Integrative Pharmacy
September 2, 2022 By Haley Nagasaki
(Globe Newswire) Vancouver — Isracann Biosciences Inc., a multi-faceted organization with a natural health medicine division (Praesidio Health) in Canada and holdings in Israel, is please to announce that it has signed a distribution agreement for Praesidio Health products with Pure Integrative Pharmacy (PURE).
“I am excited to announce our first executed distribution agreement in Canada. The Praesidio team has been working hard to bring our NPN formulations forward and get them into the hands of consumers. Pure Integrative Pharmacy, with their commitment to evidence-based complementary medicines and cutting-edge products, is a perfect fit for Praesidio Health products.
“This is the first step in delivering on our commitment to our shareholders of having products at market in Q4 2022. We are very excited to be working with the team at PURE and view this contract as the catalyst for expanding our distribution network not only in Canada, but throughout North America.” — CEO Phil Floucault
Pure Integrative Pharmacy includes 17 locations in British Columbia, Canada. Initially founded to challenge the status quo of community pharmacy, PURE works to bridge the gap between conventional and complementary medicine and become an integrative and accessible hub of health for their clients. Focusing on evidence-based efficacy and safety, PURE strives to bring together the best of conventional and complementary medicine to empower customers to take control of their health.
Praesidio is developing natural health products using an evidence-based process. Pioneering NHPs and therapeutics, Praesidio is actively developing several NHP candidates for utility in a range of conditions, including post-viral exposure prophylaxis, urological, anxiety/stress, immune boosting, and sleep aids.
Praesidio has submitted all first round product formulations to Health Canada for review and approval as natural health products.
Print this page